scPharmaceuticals Statistics Share Statistics scPharmaceuticals has 53.3M
shares outstanding. The number of shares has increased by 5.52%
in one year.
Shares Outstanding 53.3M Shares Change (YoY) 5.52% Shares Change (QoQ) 4.99% Owned by Institutions (%) 69.95% Shares Floating 36.11M Failed to Deliver (FTD) Shares 724 FTD / Avg. Volume 0.08%
Short Selling Information The latest short interest is 1.34M, so 2.51% of the outstanding
shares have been sold short.
Short Interest 1.34M Short % of Shares Out 2.51% Short % of Float 2.85% Short Ratio (days to cover) 3.26
Valuation Ratios The PE ratio is -1.85 and the forward
PE ratio is -35.12.
scPharmaceuticals's PEG ratio is
-0.05.
PE Ratio -1.85 Forward PE -35.12 PS Ratio 4.34 Forward PS 2.3 PB Ratio 11.83 P/FCF Ratio -2.23 PEG Ratio -0.05
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for scPharmaceuticals.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 7.12,
with a Debt / Equity ratio of 3.96.
Current Ratio 7.12 Quick Ratio 6.18 Debt / Equity 3.96 Debt / EBITDA -0.68 Debt / FCF -0.75 Interest Coverage -8.56
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $224.27K Profits Per Employee $-525.6K Employee Count 162 Asset Turnover 0.34 Inventory Turnover 0.82
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by 9.78% in the
last 52 weeks. The beta is 0.35, so scPharmaceuticals's
price volatility has been higher than the market average.
Beta 0.35 52-Week Price Change 9.78% 50-Day Moving Average 4.98 200-Day Moving Average 3.66 Relative Strength Index (RSI) 63.84 Average Volume (20 Days) 938,114
Income Statement In the last 12 months, scPharmaceuticals had revenue of 36.33M
and earned -85.15M
in profits. Earnings per share was -1.91.
Revenue 36.33M Gross Profit 24.97M Operating Income -64.78M Net Income -85.15M EBITDA -77.43M EBIT -77.58M Earnings Per Share (EPS) -1.91
Full Income Statement Balance Sheet The company has 75.66M in cash and 52.69M in
debt, giving a net cash position of 22.96M.
Cash & Cash Equivalents 75.66M Total Debt 52.69M Net Cash 22.96M Retained Earnings -366.49M Total Assets 80.25M Working Capital 58.3M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -70.54M
and capital expenditures -21K, giving a free cash flow of -70.56M.
Operating Cash Flow -70.54M Capital Expenditures -21K Free Cash Flow -70.56M FCF Per Share -1.58
Full Cash Flow Statement Margins Gross margin is 68.73%, with operating and profit margins of -178.29% and -234.36%.
Gross Margin 68.73% Operating Margin -178.29% Pretax Margin -234.36% Profit Margin -234.36% EBITDA Margin -213.12% EBIT Margin -178.29% FCF Margin -194.21%
